{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:09:28Z","timestamp":1781176168986,"version":"3.54.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Riparin A is a synthetic form of natural riparins. Acute scale studies that take into consideration the structure\u2013activity relationship have shown preliminary evidence of antidepressant and anxiolytic effects of riparin A, similar to that already known for other riparins. However, for better pharmacological characterization of this new compound, further studies are required. The aim of this work was to evaluate the effect of chronic treatment with riparin A (10\u2005mg\/kg; intraperitoneally) on depressive-like behavior in the forced swimming test and tail suspension test, as well as the reduction of anhedonia in the sucrose preference test, and on anxiety-like behavior in the open field and elevated plus maze apparatus, triggered in rats previously subjected to unpredictable chronic mild stress by 4 weeks. In addition, a pentobarbital-induced sleep time test was also used. Riparin A reduced the duration of immobility in both the forced swimming test and tail suspension test, as well as attenuated the anhedonia in the sucrose preference test. Furthermore, riparin A appears to produce anxiolytic effects in rats exposed to an open field and elevated plus maze, while increasing the alertness\/vigilance in rats submitted to pentobarbital-induced sleep time test, without altering their locomotor integrity. Our results suggest that chronic riparin A appears to be a potential pharmacological target for new studies on the control of depression- and anxiety-like behaviors in stressed rats.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000781","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:01:41Z","timestamp":1718276501000},"page":"303-314","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["New insights about the antidepressant-like effects of riparin A in a chronic murine model of depression"],"prefix":"10.1097","volume":"35","author":[{"given":"C\u00e1ssio","family":"Prinholato da Silva","sequence":"first","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Dias","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Iglesias","family":"Benincasa","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Barbar","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela Gon\u00e7alves Barros","family":"Perri","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia","family":"Fachin","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"},{"name":"School of Medicine, University of Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Luciano","family":"Falconi-Sobrinho","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene Oliveira","family":"Beleboni","sequence":"additional","affiliation":[{"name":"Department of Biotechnology"},{"name":"School of Medicine, University of Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions.","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0000000000000263","article-title":"Duration of initial antidepressant treatment and subsequent relapse of major depression.","volume":"35","author":"Baldessarini","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phytol.2022.10.009","article-title":"Bioactivities of isolated and synthetic riparins of Aniba riparia (NEES) MEZ (LAURACEAE): a brief review.","volume":"52","author":"Barbosa","year":"2022","journal-title":"Phytochem Lett"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/S0031-9422(00)83890-X","article-title":"Benzoyl esters and amides, styrylpyrones and neolignans from the fruits of Aniba riparia.","volume":"26","author":"Barbosa-Filho","year":"1987","journal-title":"Phytochem"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","article-title":"A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder.","volume":"21","author":"Baune","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1515\/intox-2017-0006","article-title":"Animal tests for anxiety-like and depression-like behavior in rats.","volume":"10","author":"Belovicova","year":"2017","journal-title":"Interdiscip Toxicol"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41398-021-01533-1","article-title":"Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report.","volume":"11","author":"Braund","year":"2021","journal-title":"Transl Psychiatry"},{"key":"R8-20250614","first-page":"e3638","article-title":"The mouse forced swim test.","volume":"59","author":"Can","year":"2012","journal-title":"J Vis Exp"},{"key":"R9-20250614","first-page":"348","article-title":"Adaptation of the tail suspension test to the rat.","volume":"17","author":"Chermat","year":"1986","journal-title":"J Pharmacol"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ptr.1771","article-title":"Antianxiety effects of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.","volume":"19","author":"de Sousa","year":"2005","journal-title":"Phytother Res"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1248\/bpb.30.1212","article-title":"Evaluation of effects of N-(2-hydroxybenzoyl) tyramine (riparin II) from Aniba riparia (NEES) MEZ (Lauracea) in anxiety models in mice.","volume":"30","author":"de Sousa","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1472-8206.2012.01069.x","article-title":"Involvement of monoaminergic system in the antidepressant-like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice.","volume":"28","author":"de Sousa","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2015.04.052","article-title":"Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice.","volume":"291","author":"Deng","year":"2015","journal-title":"Behav Brain Res"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/fcp.12186","article-title":"Treatment of anxiety and depression: medicinal plants in retrospect.","volume":"30","author":"Fajemiroye","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.4088\/JCP.14m09658","article-title":"Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands study of depression and anxiety.","volume":"77","author":"Gibson-Smith","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WNR.0000000000000944","article-title":"Evaluation of antidepressant activity of methanolic extract of Saraca asoca bark in a chronic unpredictable mild stress model.","volume":"29","author":"Gill","year":"2018","journal-title":"Neuroreport"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/oby.22969","article-title":"Antidepressant medications and weight change: a narrative review.","volume":"28","author":"Gill","year":"2020","journal-title":"Obesity"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.mp.4000801","article-title":"Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly.","volume":"6","author":"Govoni","year":"2001","journal-title":"Mol Psychiatry"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate.","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"e0185129","DOI":"10.1371\/journal.pone.0185129","article-title":"Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress.","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/NDT.S185295","article-title":"Influence of Xiaoyaosan on depressive-like behaviors in chronic stress-depressed rats through regulating tryptophan metabolism in hippocampus.","volume":"15","author":"Jiao","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R23-20250614","article-title":"Elevated plus maze for mice.","volume":"22","author":"Komada","year":"2008","journal-title":"J Vis Exp"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1007\/s11064-016-2029-3","article-title":"Neuroprotective, neurotrophic and anti-oxidative role of Bacopa monnieri on CUS induced model of depression in rat.","volume":"41","author":"Kumar","year":"2016","journal-title":"Neurochem Res"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00213-010-2094-2","article-title":"Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences.","volume":"214","author":"Kumar","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00391-023-02169-0","article-title":"Antidepressiva \u2013 state of the art.","volume":"56","author":"Lange-Asschenfeldt","year":"2023","journal-title":"Z Gerontol Geriat"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fpsyt.2015.00006","article-title":"An efficient chronic unpredictable stress protocol to induce stress-related responses in C57BL\/6 mice.","volume":"6","author":"Monteiro","year":"2015","journal-title":"Front Psychiatry"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","article-title":"Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling.","volume":"26","author":"Neis","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FBP.0000000000000654","article-title":"Antidepressant activity of riparin A in murine model.","volume":"32","author":"Prinholato Da Silva","year":"2021","journal-title":"Behav Pharmacol"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41386-019-0411-y","article-title":"Sleep, insomnia, and depression.","volume":"45","author":"Riemann","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neubiorev.2016.03.004","article-title":"Assessing anhedonia in depression: potentials and pitfalls.","volume":"65","author":"Rizvi","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"112487","DOI":"10.1016\/j.bbr.2020.112487","article-title":"Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.","volume":"383","author":"Sartori","year":"2020","journal-title":"Behav Brain Res"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents.","volume":"7","author":"Slattery","year":"2012","journal-title":"Nat Protoc"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2004.01.019","article-title":"Antianxiety and antidepressant effects of riparin III from Aniba riparia (Nees) Mez (Lauraceae) in mice.","volume":"78","author":"Sousa","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice.","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1472-8206.2011.00973.x","article-title":"Antidepressant-like effect of riparin II from Aniba riparia in mice: evidence for the involvement of the monoaminergic system.","volume":"27","author":"Teixeira","year":"2013","journal-title":"Fundam Clin Pharmacol"},{"key":"R47-20250614","first-page":"62","article-title":"Screening Methods in Pharmacology.","volume":"1","author":"Turner","year":"1965"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/fcp.12120","article-title":"Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus.","volume":"29","author":"Vasconcelos","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","article-title":"Estimating the true global burden of mental illness.","volume":"3","author":"Vigo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R48-20250614","article-title":"Depression and Other Common Mental Disorders: Global Health Estimates.","year":"2017"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ynstr.2016.08.001","article-title":"Reliability of the chronic mild stress model of depression: a user survey.","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol Stress"},{"key":"R44-20250614","first-page":"52587","article-title":"The forced swim test as a model of depressive-like behavior.","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J Vis Exp"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/NDT.S151107","article-title":"The depressive-like behaviors of chronic unpredictable mild stress-treated mice, ameliorated by Tibetan medicine Zuotai: Involvement in the hypothalamic\u2013pituitary\u2013 adrenal (HPA) axis pathway.","volume":"14","author":"Zhao","year":"2018","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T20:04:49Z","timestamp":1749931489000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000781","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}